{"component": "definition", "props": {"groups": [{"samples": [{"hash": "emcWAM9VWNa", "uri": "/contracts/emcWAM9VWNa#agents-information", "label": "Sales Agreement (Protara Therapeutics, Inc.)", "score": 35.3641357422, "published": true}, {"hash": "cV6y3fWTkeu", "uri": "/contracts/cV6y3fWTkeu#agents-information", "label": "Sales Agreement (Surrozen, Inc./De)", "score": 35.2217674255, "published": true}, {"hash": "gTQ8a9uYkxw", "uri": "/contracts/gTQ8a9uYkxw#agents-information", "label": "Sales Agreement (GENELUX Corp)", "score": 35.2108154297, "published": true}], "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [41, 58]}, {"key": "the-third-sentence", "type": "clause", "offset": [60, 78]}, {"key": "plan-of-distribution", "type": "definition", "offset": [146, 166]}, {"key": "indemnity-agreement", "type": "definition", "offset": [192, 211]}, {"key": "in-addition-to", "type": "clause", "offset": [220, 234]}, {"key": "the-company", "type": "definition", "offset": [254, 265]}], "snippet": "means, solely, the following information in the Prospectus: the third sentence of the eighth paragraph and the tenth paragraph under the caption \u201cPlan of Distribution\u201d in the Prospectus. This indemnity agreement will be in addition to any liability that the Company might otherwise have.", "size": 173, "hash": "0b3fce1e4991aed30f169a51e1983b39", "id": 1}, {"samples": [{"hash": "8L0B5o1rc4D", "uri": "/contracts/8L0B5o1rc4D#agents-information", "label": "Sales Agreement (F-Star Therapeutics, Inc.)", "score": 32.6139640808, "published": true}, {"hash": "9FGQOtajXYk", "uri": "/contracts/9FGQOtajXYk#agents-information", "label": "Sales Agreement (F-Star Therapeutics, Inc.)", "score": 32.244354248, "published": true}], "snippet_links": [{"key": "registration-statement-and-the-prospectus", "type": "clause", "offset": [46, 87]}, {"key": "the-final", "type": "clause", "offset": [89, 98]}, {"key": "plan-of-distribution", "type": "definition", "offset": [150, 170]}, {"key": "the-prospectus-supplement", "type": "clause", "offset": [175, 200]}, {"key": "agreement-to", "type": "clause", "offset": [225, 237]}, {"key": "supplement-to", "type": "clause", "offset": [301, 314]}, {"key": "the-foregoing", "type": "definition", "offset": [322, 335]}, {"key": "the-commission", "type": "clause", "offset": [383, 397]}, {"key": "pursuant-to-\u2587", "type": "clause", "offset": [398, 411]}, {"key": "schedules-and-other-information", "type": "clause", "offset": [478, 509]}, {"key": "other-references", "type": "clause", "offset": [611, 627]}, {"key": "incorporated-by-reference", "type": "clause", "offset": [754, 779]}, {"key": "the-case", "type": "definition", "offset": [832, 840]}, {"key": "similar-materials", "type": "clause", "offset": [962, 979]}, {"key": "in-connection-with", "type": "clause", "offset": [989, 1007]}, {"key": "placement-of", "type": "definition", "offset": [1038, 1050]}, {"key": "placement-shares", "type": "definition", "offset": [1055, 1071]}, {"key": "by-the-agent", "type": "clause", "offset": [1072, 1084]}, {"key": "outside-of-the-united-states", "type": "clause", "offset": [1085, 1113]}, {"key": "the-understanding", "type": "clause", "offset": [1153, 1170]}, {"key": "the-company-and-the", "type": "clause", "offset": [1179, 1198]}, {"key": "space-provided", "type": "clause", "offset": [1232, 1246]}, {"key": "agreement-between", "type": "clause", "offset": [1320, 1337]}, {"key": "president-and-chief-executive-officer", "type": "definition", "offset": [1472, 1509]}, {"key": "head-of", "type": "definition", "offset": [1557, 1564]}, {"key": "svb-leerink", "type": "clause", "offset": [1642, 1653]}, {"key": "the-market", "type": "definition", "offset": [1682, 1692]}, {"key": "placement-notice", "type": "definition", "offset": [1702, 1718]}, {"key": "ladies-and-gentlemen", "type": "definition", "offset": [1719, 1739]}, {"key": "terms-and", "type": "clause", "offset": [1757, 1766]}, {"key": "the-conditions", "type": "clause", "offset": [1778, 1792]}, {"key": "contained-in", "type": "definition", "offset": [1793, 1805]}, {"key": "the-sales-agreement", "type": "clause", "offset": [1806, 1825]}, {"key": "delaware-corporation", "type": "definition", "offset": [1906, 1926]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [2001, 2022]}, {"key": "shares-of-common-stock", "type": "clause", "offset": [2055, 2077]}, {"key": "par-value-per-share", "type": "clause", "offset": [2087, 2106]}, {"key": "minimum-market-price", "type": "definition", "offset": [2144, 2164]}, {"key": "provided-that", "type": "definition", "offset": [2182, 2195]}, {"key": "trading-day", "type": "definition", "offset": [2245, 2256]}, {"key": "in-section-3", "type": "clause", "offset": [2282, 2294]}, {"key": "the-agreement", "type": "clause", "offset": [2298, 2311]}, {"key": "date-of-this", "type": "clause", "offset": [2342, 2354]}, {"key": "all-shares", "type": "clause", "offset": [2398, 2408]}, {"key": "subject-of", "type": "clause", "offset": [2422, 2432]}], "snippet": "means solely the following information in the Registration Statement and the Prospectus: the final sentence of the ninth paragraph under the heading \u201cPlan of Distribution\u201d in the Prospectus Supplement. All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to \u2587\u2587\u2587\u2587\u2587. All references in this Agreement to financial statements and schedules and other information that is \u201ccontained,\u201d \u201cincluded\u201d or \u201cstated\u201d in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to \u201csupplements\u201d to the Prospectus shall include any supplements, \u201cwrappers\u201d or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States. If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. Very truly yours, F-STAR THERAPEUTICS, INC. By: /s/ \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, Ph.D. Name: \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, Ph.D. Title: President and Chief Executive Officer By: /s/ \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Title: Head of Alternative Equities From: [ ] [TITLE] F-star Therapeutics, Inc. Cc: [ ] To: SVB Leerink LLC Subject: SVB Leerink\u2014At the Market Offering\u2014Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated [\u2022], 2021 (the \u201cAgreement\u201d), by and between F-star Therapeutics, Inc., a Delaware corporation (the \u201cCompany\u201d), and SVB Leerink LLC (\u201cSVB Leerink\u201d), I hereby request on behalf of the Company that SVB Leerink sell up to [ ] shares of common stock, $0.0001 par value per share, of the Company (the \u201cShares\u201d), at a minimum market price of $ per share[; provided that no more than [ ] Shares shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)]. Sales should begin [on the date of this Placement Notice] and end on [DATE] [until all Shares that are the subject of this Placement Notice are sold]. \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, Ph.D. \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587", "size": 93, "hash": "55cb51033eafa275a4b37d80cebb7c4b", "id": 2}, {"samples": [{"hash": "5jV4vZmUzG4", "uri": "/contracts/5jV4vZmUzG4#agents-information", "label": "Sales Agreement (Revance Therapeutics, Inc.)", "score": 33.3531837463, "published": true}, {"hash": "4Vcs2Rautd7", "uri": "/contracts/4Vcs2Rautd7#agents-information", "label": "Sales Agreement (Revance Therapeutics, Inc.)", "score": 31.9048595428, "published": true}, {"hash": "iw8410SElA0", "uri": "/contracts/iw8410SElA0#agents-information", "label": "Sales Agreement (Five Prime Therapeutics, Inc.)", "score": 31.5954818726, "published": true}], "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [40, 57]}, {"key": "plan-of-distribution", "type": "definition", "offset": [110, 130]}], "snippet": "means, solely the following information in the Prospectus: the eighth and tenth paragraphs under the caption \u201cPlan of Distribution\u201d in the Prospectus.", "size": 40, "hash": "1e4a808b312b2244ac1f9c9bb64f21c4", "id": 3}, {"samples": [{"hash": "5vyPg6FGA23", "uri": "/contracts/5vyPg6FGA23#agents-information", "label": "Sales Agreement (enGene Holdings Inc.)", "score": 37.1834373474, "published": true}, {"hash": "h9xHa6SrXoD", "uri": "/contracts/h9xHa6SrXoD#agents-information", "label": "Sales Agreement (OKYO Pharma LTD)", "score": 37.1122512817, "published": true}, {"hash": "GtF6FP5EV9", "uri": "/contracts/GtF6FP5EV9#agents-information", "label": "Sales Agreement (Sagimet Biosciences Inc.)", "score": 36.6166992188, "published": true}], "snippet_links": [{"key": "registration-statement-and-the-prospectus", "type": "clause", "offset": [46, 87]}, {"key": "plan-of-distribution", "type": "definition", "offset": [128, 148]}, {"key": "the-prospectus-supplement", "type": "clause", "offset": [153, 178]}], "snippet": "means solely the following information in the Registration Statement and the Prospectus: the tenth paragraph under the heading \u201cPlan of Distribution\u201d in the Prospectus Supplement.", "size": 27, "hash": "efc320ad8d6b1c79d31b3ae84fdc17bf", "id": 4}, {"samples": [{"hash": "iQ6SWNEM8Lq", "uri": "/contracts/iQ6SWNEM8Lq#agents-information", "label": "Common Stock Sales Agreement (Allogene Therapeutics, Inc.)", "score": 30.8425731659, "published": true}], "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [40, 57]}, {"key": "fifth-paragraph", "type": "definition", "offset": [63, 78]}, {"key": "the-third-sentence", "type": "clause", "offset": [83, 101]}, {"key": "plan-of-distribution", "type": "definition", "offset": [145, 165]}, {"key": "the-foregoing", "type": "definition", "offset": [209, 222]}, {"key": "the-understanding", "type": "clause", "offset": [244, 261]}, {"key": "space-provided", "type": "clause", "offset": [319, 333]}, {"key": "agreement-between", "type": "clause", "offset": [407, 424]}, {"key": "managing-director", "type": "clause", "offset": [528, 545]}, {"key": "chief-executive-officer-and-president", "type": "clause", "offset": [619, 656]}, {"key": "the-market", "type": "definition", "offset": [721, 731]}, {"key": "placement-notice", "type": "definition", "offset": [741, 757]}, {"key": "terms-and", "type": "clause", "offset": [785, 794]}, {"key": "the-conditions", "type": "clause", "offset": [806, 820]}, {"key": "contained-in", "type": "definition", "offset": [821, 833]}, {"key": "the-sales-agreement", "type": "clause", "offset": [834, 853]}, {"key": "and-company", "type": "clause", "offset": [917, 928]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [1006, 1027]}, {"key": "par-value", "type": "clause", "offset": [1103, 1112]}, {"key": "minimum-market-price", "type": "definition", "offset": [1136, 1156]}, {"key": "date-of-this", "type": "clause", "offset": [1206, 1218]}, {"key": "all-shares", "type": "clause", "offset": [1259, 1269]}, {"key": "gross-proceeds", "type": "clause", "offset": [1435, 1449]}, {"key": "sales-of-common-stock", "type": "clause", "offset": [1459, 1480]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [1497, 1520]}, {"key": "the-undersigned", "type": "definition", "offset": [1542, 1557]}, {"key": "duly-qualified", "type": "definition", "offset": [1563, 1577]}, {"key": "delaware-corporation", "type": "definition", "offset": [1661, 1681]}, {"key": "does-hereby-certify", "type": "clause", "offset": [1683, 1702]}, {"key": "pursuant-to-section", "type": "definition", "offset": [1750, 1769]}, {"key": "company-and-\u2587", "type": "clause", "offset": [1857, 1870]}, {"key": "knowledge-of", "type": "definition", "offset": [1917, 1929]}, {"key": "in-section-6", "type": "clause", "offset": [2001, 2013]}, {"key": "to-the-extent", "type": "clause", "offset": [2041, 2054]}, {"key": "qualifications-and-exceptions", "type": "clause", "offset": [2106, 2135]}, {"key": "relating-to", "type": "definition", "offset": [2154, 2165]}, {"key": "material-adverse-change", "type": "definition", "offset": [2181, 2204]}, {"key": "true-and-correct", "type": "clause", "offset": [2210, 2226]}, {"key": "date-hereof", "type": "clause", "offset": [2244, 2255]}, {"key": "force-and-effect", "type": "clause", "offset": [2270, 2286]}, {"key": "in-all-material-respects", "type": "definition", "offset": [2607, 2631]}, {"key": "the-company-has", "type": "definition", "offset": [2921, 2936]}, {"key": "all-agreements", "type": "clause", "offset": [2951, 2965]}, {"key": "all-conditions", "type": "definition", "offset": [2980, 2994]}, {"key": "prior-to-the", "type": "clause", "offset": [3074, 3086]}], "snippet": "means, solely the following information in the Prospectus: the fifth paragraph and the third sentence of the eighth paragraph under the caption \u201cPlan of Distribution\u201d in the Prospectus. US-DOCS\\111349286.7 If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen. Very truly yours, By: __/s/ \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Murphy_________ Name: \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Title: Managing Director By: __/s/ \u2587\u2587\u2587\u2587\u2587 Chang_____________ Name: \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, M.D., Ph.D. Title: Chief Executive Officer and President US-DOCS\\111349286.7 From: [ ] Cc: [ ] To: [ ] Subject: Cowen at the Market Offering\u2014Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Allogene Therapeutics, Inc. (the \u201cCompany\u201d), and \u2587\u2587\u2587\u2587\u2587 and Company, LLC (\u201cCowen\u201d) dated November 5, 2019 (the \u201cAgreement\u201d), I hereby request on behalf of the Company that Cowen sell up to [[ ] shares] [$_____] of the Company\u2019s common stock, par value [____] per share, at a minimum market price of $_______ per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold]. US-DOCS\\111349286.7 \u2022 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2022 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2022 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2022 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 US-DOCS\\111349286.7 Cowen shall be paid compensation up to 3.0% of the gross proceeds from the sales of Common Stock pursuant to the terms of this Agreement. US-DOCS\\111349286.7 The undersigned, the duly qualified and elected _______________________, of Allogene Therapeutics, Inc. (\u201cCompany\u201d), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company, pursuant to Section 7(m) of the Sales Agreement dated November 5, 2019 (the \u201cSales Agreement\u201d) between the Company and \u2587\u2587\u2587\u2587\u2587 and Company, LLC, that to the best of the knowledge of the undersigned.\n(i) The representations and warranties of the Company in Section 6 of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date; and\n(ii) The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.", "size": 19, "hash": "334762b591af741747805fd659041c11", "id": 5}, {"samples": [{"hash": "cn7x13FY4rF", "uri": "/contracts/cn7x13FY4rF#agents-information", "label": "Sales Agreement (Otonomy, Inc.)", "score": 30.5893230438, "published": true}, {"hash": "75zu5HDfqhg", "uri": "/contracts/75zu5HDfqhg#agents-information", "label": "Sales Agreement (Otonomy, Inc.)", "score": 30.5893230438, "published": true}], "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [40, 57]}, {"key": "the-third-sentence", "type": "clause", "offset": [59, 77]}, {"key": "plan-of-distribution", "type": "definition", "offset": [121, 141]}, {"key": "the-foregoing", "type": "definition", "offset": [165, 178]}, {"key": "the-understanding", "type": "clause", "offset": [200, 217]}, {"key": "space-provided", "type": "clause", "offset": [275, 289]}, {"key": "agreement-between", "type": "clause", "offset": [363, 380]}, {"key": "managing-director", "type": "clause", "offset": [473, 490]}, {"key": "financial-and-business", "type": "clause", "offset": [546, 568]}, {"key": "the-market", "type": "definition", "offset": [621, 631]}, {"key": "placement-notice", "type": "definition", "offset": [641, 657]}, {"key": "terms-and", "type": "clause", "offset": [685, 694]}, {"key": "the-conditions", "type": "clause", "offset": [706, 720]}, {"key": "contained-in", "type": "definition", "offset": [721, 733]}, {"key": "the-sales-agreement", "type": "clause", "offset": [734, 753]}, {"key": "and-company", "type": "clause", "offset": [803, 814]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [890, 911]}, {"key": "shares-of-the-company", "type": "definition", "offset": [938, 959]}, {"key": "par-value", "type": "clause", "offset": [976, 985]}, {"key": "minimum-market-price", "type": "definition", "offset": [1009, 1029]}, {"key": "date-of-this", "type": "clause", "offset": [1079, 1091]}, {"key": "all-shares", "type": "clause", "offset": [1132, 1142]}, {"key": "chief-executive-officer", "type": "clause", "offset": [1220, 1243]}, {"key": "equal-to", "type": "definition", "offset": [1358, 1366]}, {"key": "gross-proceeds", "type": "clause", "offset": [1379, 1393]}, {"key": "sales-of-common-stock", "type": "clause", "offset": [1403, 1424]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [1441, 1464]}], "snippet": "means, solely the following information in the Prospectus: the third sentence of the eighth paragraph under the caption \u201cPlan of Distribution\u201d in the Prospectus. If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen. Very truly yours, By: /s/ \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Title: Managing Director By: /s/ \u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587 Title: Chief Financial and Business Officer From: [ ] Cc: [ ] To: [ ] Subject: Cowen at the Market Offering\u2014Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Otonomy, Inc. (the \u201cCompany\u201d), and \u2587\u2587\u2587\u2587\u2587 and Company, LLC (\u201cCowen\u201d) dated August 4, 2021 (the \u201cAgreement\u201d), I hereby request on behalf of the Company that Cowen sell up to [ ] shares of the Company\u2019s common stock, par value $0.001 per share, at a minimum market price of $_______ per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold]. \u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587, Chief Financial & Business Officer \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587, Chief Executive Officer & President \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587 Managing Director \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Managing Director Cowen shall be paid compensation equal to 3.0% of the gross proceeds from the sales of Common Stock pursuant to the terms of this Agreement.", "size": 12, "hash": "2862d6d2aed115bf86893212c0819bca", "id": 6}, {"samples": [{"hash": "2EPGcw6NYqG", "uri": "/contracts/2EPGcw6NYqG#agents-information", "label": "Sales Agreement (G1 Therapeutics, Inc.)", "score": 29.4517459869, "published": true}], "snippet_links": [{"key": "in-the-prospectus", "type": "clause", "offset": [40, 57]}, {"key": "fifth-paragraph", "type": "definition", "offset": [63, 78]}, {"key": "plan-of-distribution", "type": "definition", "offset": [98, 118]}, {"key": "the-foregoing", "type": "definition", "offset": [142, 155]}, {"key": "the-understanding", "type": "clause", "offset": [177, 194]}, {"key": "space-provided", "type": "clause", "offset": [252, 266]}, {"key": "agreement-between", "type": "clause", "offset": [340, 357]}, {"key": "managing-director", "type": "clause", "offset": [444, 461]}, {"key": "chief-financial-officer", "type": "definition", "offset": [523, 546]}, {"key": "the-market", "type": "definition", "offset": [591, 601]}, {"key": "placement-notice", "type": "definition", "offset": [611, 627]}, {"key": "terms-and", "type": "clause", "offset": [655, 664]}, {"key": "the-conditions", "type": "clause", "offset": [676, 690]}, {"key": "contained-in", "type": "definition", "offset": [691, 703]}, {"key": "the-sales-agreement", "type": "clause", "offset": [704, 723]}, {"key": "delaware-corporation", "type": "definition", "offset": [757, 777]}, {"key": "and-company", "type": "clause", "offset": [805, 816]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [880, 901]}, {"key": "shares-of-the-company", "type": "definition", "offset": [928, 949]}, {"key": "common-stock", "type": "clause", "offset": [952, 964]}, {"key": "par-value", "type": "clause", "offset": [966, 975]}, {"key": "minimum-market-price", "type": "definition", "offset": [999, 1019]}, {"key": "date-of-this", "type": "clause", "offset": [1069, 1081]}, {"key": "all-shares", "type": "clause", "offset": [1122, 1132]}, {"key": "the-shares", "type": "clause", "offset": [1173, 1183]}, {"key": "chief-executive-officer", "type": "clause", "offset": [1235, 1258]}], "snippet": "means, solely the following information in the Prospectus: the fifth paragraph under the caption \u201cPlan of Distribution\u201d in the Prospectus. If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen. Very truly yours, By: /s/ \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Title: Managing Director By: /s/ \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Title: Chief Financial Officer From: [ ] Cc: [ ] To: [ ] Subject: Cowen at the Market Offering\u2014Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement between G1 Therapeutics, Inc., a Delaware corporation (the \u201cCompany\u201d), and \u2587\u2587\u2587\u2587\u2587 and Company, LLC (\u201cCowen\u201d) dated [ ](the \u201cAgreement\u201d), I hereby request on behalf of the Company that Cowen sell up to [ ] shares of the Company\u2019s common stock, par value 0.0001 per share, at a minimum market price of $_______ per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold] [the aggregate sales price of the shares reaches $[ ]]. G1 Therapeutics, Inc. \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 (Chief Executive Officer) \u2587\u2587\u2587\u2587\u2587\u2587\u2587 (Buck) \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 (Chief Financial Officer) \u2587\u2587\u2587\u2587\u2587 and Company, LLC \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 (Director) \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 (Managing Director)", "size": 12, "hash": "f4a27e0bb4fc56167282382b114bb5b1", "id": 7}, {"samples": [{"hash": "5LODH8KTMt", "uri": "/contracts/5LODH8KTMt#agents-information", "label": "Sales Agreement (Trevi Therapeutics, Inc.)", "score": 31.4832305908, "published": true}], "snippet_links": [{"key": "registration-statement-and-the-prospectus", "type": "clause", "offset": [46, 87]}, {"key": "the-last-sentence", "type": "clause", "offset": [89, 106]}, {"key": "plan-of-distribution", "type": "definition", "offset": [174, 194]}, {"key": "sales-agreement-prospectus", "type": "definition", "offset": [203, 229]}, {"key": "agreement-to", "type": "clause", "offset": [254, 266]}, {"key": "supplement-to", "type": "clause", "offset": [330, 343]}, {"key": "the-foregoing", "type": "definition", "offset": [351, 364]}, {"key": "the-commission", "type": "clause", "offset": [412, 426]}, {"key": "pursuant-to-\u2587", "type": "clause", "offset": [427, 440]}, {"key": "schedules-and-other-information", "type": "clause", "offset": [507, 538]}, {"key": "other-references", "type": "clause", "offset": [640, 656]}, {"key": "incorporated-by-reference", "type": "clause", "offset": [783, 808]}, {"key": "the-case", "type": "definition", "offset": [861, 869]}, {"key": "similar-materials", "type": "clause", "offset": [991, 1008]}, {"key": "in-connection-with", "type": "clause", "offset": [1018, 1036]}, {"key": "placement-of", "type": "definition", "offset": [1067, 1079]}, {"key": "placement-shares", "type": "definition", "offset": [1084, 1100]}, {"key": "by-the-agent", "type": "clause", "offset": [1101, 1113]}, {"key": "outside-of-the-united-states", "type": "clause", "offset": [1114, 1142]}, {"key": "the-understanding", "type": "clause", "offset": [1182, 1199]}, {"key": "the-company-and-the", "type": "clause", "offset": [1208, 1227]}, {"key": "space-provided", "type": "clause", "offset": [1261, 1275]}, {"key": "agreement-between", "type": "clause", "offset": [1349, 1366]}, {"key": "chief-executive-officer", "type": "clause", "offset": [1461, 1484]}, {"key": "head-of", "type": "definition", "offset": [1532, 1539]}, {"key": "svb-leerink", "type": "clause", "offset": [1616, 1627]}, {"key": "the-market", "type": "definition", "offset": [1656, 1666]}, {"key": "placement-notice", "type": "definition", "offset": [1676, 1692]}, {"key": "ladies-and-gentlemen", "type": "definition", "offset": [1693, 1713]}, {"key": "terms-and", "type": "clause", "offset": [1731, 1740]}, {"key": "the-conditions", "type": "clause", "offset": [1752, 1766]}, {"key": "contained-in", "type": "definition", "offset": [1767, 1779]}, {"key": "delaware-corporation", "type": "definition", "offset": [1883, 1903]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [1978, 1999]}, {"key": "shares-of-common-stock", "type": "clause", "offset": [2032, 2054]}, {"key": "par-value-per-share", "type": "clause", "offset": [2063, 2082]}, {"key": "minimum-market-price", "type": "definition", "offset": [2120, 2140]}, {"key": "provided-that", "type": "definition", "offset": [2158, 2171]}, {"key": "trading-day", "type": "definition", "offset": [2221, 2232]}, {"key": "in-section-3", "type": "clause", "offset": [2258, 2270]}, {"key": "the-agreement", "type": "clause", "offset": [2274, 2287]}, {"key": "date-of-this", "type": "clause", "offset": [2318, 2330]}, {"key": "all-shares", "type": "clause", "offset": [2374, 2384]}, {"key": "subject-of", "type": "clause", "offset": [2398, 2408]}], "snippet": "means solely the following information in the Registration Statement and the Prospectus: the last sentence of the eighth paragraph and the tenth paragraph under the heading \u201cPlan of Distribution\u201d in the Sales Agreement Prospectus. All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to \u2587\u2587\u2587\u2587\u2587. All references in this Agreement to financial statements and schedules and other information that is \u201ccontained,\u201d \u201cincluded\u201d or \u201cstated\u201d in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to \u201csupplements\u201d to the Prospectus shall include any supplements, \u201cwrappers\u201d or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States. If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. Very truly yours, By: /s/ \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Title: Chief Executive Officer By: /s/ \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Title: Head of Alternative Equities From: [ ] [TITLE] Trevi Therapeutics, Inc. Cc: [ ] To: SVB Leerink LLC Subject: SVB Leerink\u2014At the Market Offering\u2014Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated June 26, 2020 (the \u201cAgreement\u201d), by and between Trevi Therapeutics, Inc., a Delaware corporation (the \u201cCompany\u201d), and SVB Leerink LLC (\u201cSVB Leerink\u201d), I hereby request on behalf of the Company that SVB Leerink sell up to [ ] shares of common stock, $0.001 par value per share, of the Company (the \u201cShares\u201d), at a minimum market price of $ per share[; provided that no more than [ ] Shares shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)]. Sales should begin [on the date of this Placement Notice] and end on [DATE] [until all Shares that are the subject of this Placement Notice are sold]. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. Good \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587", "size": 12, "hash": "146621d0eb63e42234b3ac035535f3a3", "id": 8}, {"samples": [{"hash": "3I8WHKHP8Nh", "uri": "/contracts/3I8WHKHP8Nh#agents-information", "label": "Sales Agreement (LENSAR, Inc.)", "score": 32.266254425, "published": true}], "snippet_links": [{"key": "registration-statement-and-the-prospectus", "type": "clause", "offset": [46, 87]}, {"key": "the-last-sentence", "type": "clause", "offset": [89, 106]}, {"key": "plan-of-distribution", "type": "definition", "offset": [174, 194]}, {"key": "the-prospectus-supplement", "type": "clause", "offset": [199, 224]}, {"key": "agreement-to", "type": "clause", "offset": [249, 261]}, {"key": "supplement-to", "type": "clause", "offset": [325, 338]}, {"key": "the-foregoing", "type": "definition", "offset": [346, 359]}, {"key": "the-commission", "type": "clause", "offset": [407, 421]}, {"key": "pursuant-to-\u2587", "type": "clause", "offset": [422, 435]}, {"key": "schedules-and-other-information", "type": "clause", "offset": [502, 533]}, {"key": "other-references", "type": "clause", "offset": [635, 651]}, {"key": "incorporated-by-reference", "type": "clause", "offset": [778, 803]}, {"key": "the-case", "type": "definition", "offset": [856, 864]}, {"key": "similar-materials", "type": "clause", "offset": [986, 1003]}, {"key": "in-connection-with", "type": "clause", "offset": [1013, 1031]}, {"key": "placement-of", "type": "definition", "offset": [1062, 1074]}, {"key": "placement-shares", "type": "definition", "offset": [1079, 1095]}, {"key": "by-the-agent", "type": "clause", "offset": [1096, 1108]}, {"key": "outside-of-the-united-states", "type": "clause", "offset": [1109, 1137]}, {"key": "the-understanding", "type": "clause", "offset": [1177, 1194]}, {"key": "the-company-and-the", "type": "clause", "offset": [1203, 1222]}, {"key": "space-provided", "type": "clause", "offset": [1256, 1270]}, {"key": "agreement-between", "type": "clause", "offset": [1344, 1361]}, {"key": "chief-executive-officer", "type": "clause", "offset": [1466, 1489]}, {"key": "head-of", "type": "definition", "offset": [1537, 1544]}, {"key": "svb-leerink", "type": "clause", "offset": [1609, 1620]}, {"key": "the-market", "type": "definition", "offset": [1649, 1659]}, {"key": "placement-notice", "type": "definition", "offset": [1669, 1685]}, {"key": "ladies-and-gentlemen", "type": "definition", "offset": [1686, 1706]}, {"key": "terms-and", "type": "clause", "offset": [1724, 1733]}, {"key": "the-conditions", "type": "clause", "offset": [1745, 1759]}, {"key": "contained-in", "type": "definition", "offset": [1760, 1772]}, {"key": "the-sales-agreement", "type": "clause", "offset": [1773, 1792]}, {"key": "delaware-corporation", "type": "definition", "offset": [1864, 1884]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [1959, 1980]}, {"key": "shares-of-common-stock", "type": "clause", "offset": [2013, 2035]}, {"key": "par-value-per-share", "type": "clause", "offset": [2043, 2062]}, {"key": "minimum-market-price", "type": "definition", "offset": [2100, 2120]}, {"key": "provided-that", "type": "definition", "offset": [2138, 2151]}, {"key": "trading-day", "type": "definition", "offset": [2201, 2212]}, {"key": "in-section-3", "type": "clause", "offset": [2238, 2250]}, {"key": "the-agreement", "type": "clause", "offset": [2254, 2267]}, {"key": "date-of-this", "type": "clause", "offset": [2298, 2310]}, {"key": "all-shares", "type": "clause", "offset": [2354, 2364]}, {"key": "subject-of", "type": "clause", "offset": [2378, 2388]}], "snippet": "means solely the following information in the Registration Statement and the Prospectus: the last sentence of the eighth paragraph and the tenth paragraph under the heading \u201cPlan of Distribution\u201d in the Prospectus Supplement. All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to \u2587\u2587\u2587\u2587\u2587. All references in this Agreement to financial statements and schedules and other information that is \u201ccontained,\u201d \u201cincluded\u201d or \u201cstated\u201d in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to \u201csupplements\u201d to the Prospectus shall include any supplements, \u201cwrappers\u201d or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States. If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. Very truly yours, By: /s/ \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587 Title: Chief Executive Officer By: /s/ \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Title: Head of Alternative Equities From: [ ] [TITLE] LENSAR, INC. Cc: [ ] To: SVB Leerink LLC Subject: SVB Leerink\u2014At the Market Offering\u2014Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated April 8, 2021 (the \u201cAgreement\u201d), by and between LENSAR, Inc., a Delaware corporation (the \u201cCompany\u201d), and SVB Leerink LLC (\u201cSVB Leerink\u201d), I hereby request on behalf of the Company that SVB Leerink sell up to [ ] shares of common stock, $0.01 par value per share, of the Company (the \u201cShares\u201d), at a minimum market price of $ per share[; provided that no more than [ ] Shares shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)]. Sales should begin [on the date of this Placement Notice] and end on [DATE] [until all Shares that are the subject of this Placement Notice are sold]. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587", "size": 11, "hash": "dd081ebd9147586e348624611a169b59", "id": 9}, {"samples": [{"hash": "7kLRU64p496", "uri": "/contracts/7kLRU64p496#agents-information", "label": "Sales Agreement (Kazia Therapeutics LTD)", "score": 37.2080764771, "published": true}], "snippet_links": [{"key": "registration-statement-and-the-prospectus", "type": "clause", "offset": [46, 87]}, {"key": "plan-of-distribution", "type": "definition", "offset": [142, 162]}, {"key": "the-prospectus-supplement", "type": "clause", "offset": [167, 192]}, {"key": "agreement-to", "type": "clause", "offset": [217, 229]}, {"key": "supplement-to", "type": "clause", "offset": [293, 306]}, {"key": "the-foregoing", "type": "definition", "offset": [314, 327]}, {"key": "the-commission", "type": "clause", "offset": [375, 389]}, {"key": "pursuant-to-\u2587", "type": "clause", "offset": [390, 403]}, {"key": "schedules-and-other-information", "type": "clause", "offset": [470, 501]}, {"key": "other-references", "type": "clause", "offset": [603, 619]}, {"key": "incorporated-by-reference", "type": "clause", "offset": [746, 771]}, {"key": "the-case", "type": "definition", "offset": [824, 832]}, {"key": "similar-materials", "type": "clause", "offset": [954, 971]}, {"key": "in-connection-with", "type": "clause", "offset": [981, 999]}, {"key": "placement-of", "type": "definition", "offset": [1030, 1042]}, {"key": "by-the-agent", "type": "clause", "offset": [1062, 1074]}, {"key": "outside-of-the-united-states", "type": "clause", "offset": [1075, 1103]}, {"key": "the-understanding", "type": "clause", "offset": [1143, 1160]}, {"key": "the-company-and-the", "type": "clause", "offset": [1169, 1188]}, {"key": "space-provided", "type": "clause", "offset": [1222, 1236]}, {"key": "agreement-between", "type": "clause", "offset": [1310, 1327]}, {"key": "chief-executive-officer", "type": "clause", "offset": [1418, 1441]}, {"key": "head-of", "type": "definition", "offset": [1489, 1496]}, {"key": "the-market", "type": "definition", "offset": [1626, 1636]}, {"key": "placement-notice", "type": "definition", "offset": [1646, 1662]}, {"key": "ladies-and-gentlemen", "type": "definition", "offset": [1663, 1683]}, {"key": "terms-and", "type": "clause", "offset": [1701, 1710]}, {"key": "the-conditions", "type": "clause", "offset": [1722, 1736]}, {"key": "contained-in", "type": "definition", "offset": [1737, 1749]}, {"key": "the-sales-agreement", "type": "clause", "offset": [1750, 1769]}, {"key": "an-australian", "type": "clause", "offset": [1870, 1883]}, {"key": "company-limited", "type": "clause", "offset": [1891, 1906]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [2001, 2022]}, {"key": "american-depositary-shares", "type": "definition", "offset": [2060, 2086]}, {"key": "fully-paid", "type": "clause", "offset": [2138, 2148]}, {"key": "shares-of-the-company", "type": "definition", "offset": [2158, 2179]}, {"key": "par-value-per-share", "type": "clause", "offset": [2184, 2203]}, {"key": "minimum-market-price", "type": "definition", "offset": [2233, 2253]}, {"key": "provided-that", "type": "definition", "offset": [2271, 2284]}, {"key": "trading-day", "type": "definition", "offset": [2342, 2353]}, {"key": "in-section-3", "type": "clause", "offset": [2379, 2391]}, {"key": "the-agreement", "type": "clause", "offset": [2395, 2408]}, {"key": "date-of-this", "type": "clause", "offset": [2439, 2451]}, {"key": "subject-of", "type": "clause", "offset": [2527, 2537]}], "snippet": "means solely the following information in the Registration Statement and the Prospectus: the seventh and eighth paragraphs under the heading \u201cPlan of Distribution\u201d in the Prospectus Supplement. All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to \u2587\u2587\u2587\u2587\u2587. All references in this Agreement to financial statements and schedules and other information that is \u201ccontained,\u201d \u201cincluded\u201d or \u201cstated\u201d in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to \u201csupplements\u201d to the Prospectus shall include any supplements, \u201cwrappers\u201d or similar materials prepared in connection with any offering, sale or private placement of any Placement ADSs by the Agent outside of the United States. If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. Very truly yours, By: /s/ \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Title: Chief Executive Officer By: /s/ \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Name: \u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587 Title: Head of Alternative Equities From: [ ] [TITLE] \u2587\u2587\u2587\u2587\u2587 Therapeutics Limited Cc: [ ] To: Leerink Partners LLC Subject: Leerink Partners \u2014At the Market Offering\u2014Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated March 17, 2026 (the \u201cAgreement\u201d), by and between \u2587\u2587\u2587\u2587\u2587 Therapeutics Limited ACN 063 259 754, an Australian public company limited by shares (the \u201cCompany\u201d), and Leerink Partners LLC (\u201cLeerink Partners\u201d), I hereby request on behalf of the Company that Leerink Partners sell up to [ ] American Depositary Shares (the \u201cADSs\u201d), each representing five hundred (500) fully paid ordinary shares of the Company, no par value per share (the \u201cPlacement ADSs\u201d), at a minimum market price of $ per share[; provided that no more than [ ] Placement ADSs shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)]. Sales should begin [on the date of this Placement Notice] and end on [DATE] [until all Placement ADSs that are the subject of this Placement Notice are sold]. \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587", "size": 10, "hash": "6e748142c7a3ec56f349e05589134cb9", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIbYWdlbnRzLWluZm9ybWF0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means, solely, the following information in the Prospectus: the third sentence of the eighth paragraph and the tenth paragraph under the caption \u201cPlan of Distribution\u201d in the Prospectus. This indemnity agreement will be in addition to any liability that the Company might otherwise have.", "size": 595, "title": "Agent\u2019s Information", "id": "agents-information", "examples": ["The representations and warranties set forth in the two immediately preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information relating to <strong>Agent\u2019s Information</strong> (as defined below)."], "related": [["access-information", "Access Information", "Access Information"], ["information-materials", "Information Materials", "Information Materials"], ["private-information", "Private information", "Private information"], ["client-information", "Client Information", "Client Information"], ["keeping-information-confidential", "Keeping information confidential", "Keeping information confidential"]], "related_snippets": [], "updated": "2026-05-29T05:44:52+00:00"}, "json": true, "cursor": ""}}